Prof. Holowach Thurston evaluated the clinical aspects of epilepsy including long-term studies examining anticonvulsant withdrawal effects in the pediatric patients suffering from epilepsy and concluded various risk factors for seizure recurrence. [3] Prof. Holowach Thurston had profound interest in cerebral metabolic studies in relation to neurological aspects of the neonate and developmental brain chemistry including the effects of malnutrition on pediatric cerebral energy metabolism, effect of developing brain in relation of the exhaustion of energy reserves, cerebral uptake and utilization of energy sources such as fructose, and strongly advocated that serum glucose level was an unreliable index of brain glucose and in fact glucose supplementation improved outcome in infants and small children in the anoxic events, which is contrary to the commonly observed phenomenon in adult population. [4] She also remained deeply involved in investigating the activity of various mitochondrial enzymes and intermediates in salicylate toxicity and experimental neonatal asphyxia. [5] She did a detailed analysis of adverse effects of commonly prescribed medications for infants and children such as prolonged therapy with insulin, glycerol, glucose, hydrocortisone, and aminophylline. She along with her spouse, late Prof. Donald L. Thurston, Chairman of Pediatrics at the St. Louis Children's Hospital, jointly carried out various collaborative research projects for utility of newer antiepileptic therapy, for example, ACTH and acetazolamide in children. In another collaborative study, with Steve Rothman, she evaluated neuroprotective effect of ketamine and the delayed neurotoxic effects of excitatoxic amino acids.
Prof. Holowach Thurston at her laboratory was also involved with anticonvulsants and amino acid metabolism in human liver and brain, the role of taurine in cerebral osmoregulation, and factors governing cerebral water and salt balance. [5, 6] Prof. Holowach Thurston also developed methods of metabolic assays of cerebrospinal fluid for the detection of various inborn errors of metabolism. She was also credited first to investigate the possible application of valproic acid as neuroprotective effect under hypoxic-ischemic conditions and the potential roles of pantothenic acid, carnitine, and acetylcysteine in the prevention of valproate-induced hepatic toxicity.
